| scholarly article | Q13442814 |
| P50 | author | James R. Baker Jr. | Q87807800 |
| P2093 | author name string | Shraddha S Nigavekar | |
| Thommey P Thomas | |||
| Istvan J Majoros | |||
| Jolanta F Kukowska-Latallo | |||
| Kimberly A Candido | |||
| Lajos P Balogh | |||
| Mohamed K Khan | |||
| Zhengyi Cao | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 5317-5324 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer | |
| P478 | volume | 65 |
| Q35932503 | "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo |
| Q33995502 | A general mechanism for intracellular toxicity of metal-containing nanoparticles. |
| Q38842699 | A new application of plant virus nanoparticles as drug delivery in breast cancer |
| Q35700348 | A photochemical approach for controlled drug release in targeted drug delivery |
| Q33718722 | A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates |
| Q35130646 | A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas |
| Q42007121 | A target-specific oral formulation of Doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer |
| Q34972071 | Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography |
| Q37991742 | Advancement in multifunctional nanoparticles for the effective treatment of cancer. |
| Q38255901 | Advances in targeting strategies for nanoparticles in cancer imaging and therapy |
| Q37234202 | Advances of cancer therapy by nanotechnology |
| Q28658189 | An emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnology |
| Q80189238 | Analysis of fullerene-based nanomaterial in serum matrix by CE |
| Q60895177 | Analysis of nanoparticle delivery to tumours |
| Q56889547 | Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy |
| Q35652859 | Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay |
| Q38266436 | Application of PAMAM dendrimers in optical sensing |
| Q57380327 | Applications of Dendrimers in Drug Delivery Agents, Diagnosis, Therapy, and Detection |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q38006425 | Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease |
| Q38848923 | Arg-Gly-Asp-D-Phe-Lys peptide-modified PEGylated dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of breast carcinoma |
| Q33598717 | Avidity mechanism of dendrimer-folic acid conjugates |
| Q37198647 | Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles |
| Q36410213 | Best practices for purification and characterization of PAMAM dendrimer |
| Q33771285 | Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo |
| Q37687066 | Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation |
| Q34194191 | Bioengineering strategies for designing targeted cancer therapies |
| Q81610160 | Biofunctionalized targeted nanoparticles for therapeutic applications |
| Q37793942 | Biomedical applications of dendrimers: a tutorial |
| Q36768786 | Biomimetic delivery with micro- and nanoparticles |
| Q41104930 | Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery. |
| Q46850227 | CE of poly(amidoamine) succinamic acid dendrimers using a poly(vinyl alcohol)-coated capillary |
| Q39702119 | Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors |
| Q25256822 | Canine parvovirus-like particles, a novel nanomaterial for tumor targeting |
| Q28391763 | Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice |
| Q33585496 | Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations |
| Q34011165 | Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance |
| Q36654768 | Characterization of Folic Acid and Poly(amidoamine) Dendrimer Interactions with Folate Binding Protein: A Force-Pulling Study. |
| Q33758388 | Characterization of Nanoparticles by Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry |
| Q36194380 | Chemotherapy targeting by DNA capture in viral protein particles |
| Q61445534 | Combined antitumoral effects of pretubulysin and methotrexate |
| Q36334384 | Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice |
| Q34054331 | Comparison of MRI properties between derivatized DTPA and DOTA gadolinium–dendrimer conjugates |
| Q33983843 | Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells |
| Q30436655 | Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology |
| Q33524689 | Cooperative nanomaterial system to sensitize, target, and treat tumors |
| Q34622581 | Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform |
| Q33892483 | Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth |
| Q57777287 | Cytotoxicity of PAMAM, PPI and maltose modified PPIdendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells |
| Q37194020 | Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy |
| Q26743392 | Dendrimer Prodrugs |
| Q37939967 | Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. |
| Q36324230 | Dendrimer-Functionalized Laponite Nanodisks as a Platform for Anticancer Drug Delivery |
| Q39697618 | Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue |
| Q35624762 | Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. |
| Q38820422 | Dendrimer-based nanocarriers: a versatile platform for drug delivery |
| Q38340442 | Dendrimer-entrapped metal colloids as imaging agents |
| Q37886750 | Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery. |
| Q92255519 | Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications |
| Q26771189 | Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications |
| Q34369684 | Dendrimers in medical nanotechnology |
| Q36945843 | Dendritic systems in drug delivery applications |
| Q42846533 | Deposition of silver nanoparticles on dendrimer functionalized multiwalled carbon nanotubes: synthesis, characterization and antimicrobial activity |
| Q35908427 | Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics |
| Q37383231 | Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic |
| Q37834336 | Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives |
| Q33640942 | Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery |
| Q34952473 | Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform |
| Q34473653 | Designing dendrimers for biological applications |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q37346613 | Designing immunotherapies to thwart drug abuse |
| Q36427742 | Detecting cryptic epitopes created by nanoparticles. |
| Q57252649 | Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells |
| Q35025058 | Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect |
| Q52583647 | Distributions: The Importance of the Chemist's Molecular View for Biological Materials. |
| Q37809880 | Drug delivery using multifunctional dendrimers and hyperbranched polymers |
| Q34666766 | Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions |
| Q37417569 | Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells |
| Q38940163 | Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells |
| Q37091154 | Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells |
| Q38706507 | Effectiveness of nanoencapsulated methotrexate against osteosarcoma cells: in vitro cytotoxicity under dynamic conditions |
| Q33917755 | Enabling individualized therapy through nanotechnology |
| Q90581683 | Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine |
| Q33371959 | Enhanced imaging and accelerated photothermalysis of A549 human lung cancer cells by gold nanospheres |
| Q34573279 | Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles |
| Q36352928 | Essential properties of drug-targeting delivery systems |
| Q64355675 | Estrogen receptor subcellular localization and cardiometabolism |
| Q38080724 | Exploiting the physicochemical properties of dendritic polymers for environmental and biological applications. |
| Q33318156 | Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy |
| Q49154861 | Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity |
| Q37776257 | Folate-Targeted Therapies for Cancer |
| Q38840971 | Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. |
| Q37396154 | Folate-mediated Cell Uptake of Shell-crosslinked Spheres and Cylinders |
| Q35201491 | Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis |
| Q42838745 | Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells |
| Q49963085 | Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials |
| Q99571264 | Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo |
| Q37772516 | Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. |
| Q38946521 | Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations |
| Q61445206 | Graphene Oxide as a Multifunctional Platform for Intracellular Delivery, Imaging, and Cancer Sensing |
| Q34034551 | HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb |
| Q35552351 | Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation |
| Q34590348 | Highly stable, ligand-clustered “patchy” micelle nanocarriers for systemic tumor targeting |
| Q28483980 | In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin |
| Q39227278 | In vitro evaluation of dendrimer-polymer hybrid nanoparticles on their controlled cellular targeting kinetics. |
| Q36314783 | In vivo biodistribution of dendrimers and dendrimer nanocomposites -- implications for cancer imaging and therapy |
| Q44205806 | In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges |
| Q34135619 | Influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers |
| Q41843285 | Insulin-Based Regulation of Glucose-functionalized Nanoparticle Uptake in Muscle Cells. |
| Q47244000 | Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs). |
| Q34051454 | Interactive Design Strategy for a Multi-Functional PAMAM Dendrimer-Based Nano-Therapeutic Using Computational Models and Experimental Analysis |
| Q30478114 | Is there a shift to "active nanostructures"? |
| Q35074580 | Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia |
| Q37425224 | Ligand-based targeted therapy for cancer tissue |
| Q41548406 | MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model |
| Q26852723 | Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery |
| Q89801078 | Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach |
| Q34152021 | Methotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform |
| Q34247680 | Methotrexate: a detailed review on drug delivery and clinical aspects |
| Q38827049 | Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release |
| Q36920038 | Molecular dynamics studies of the size, shape, and internal structure of 0% and 90% acetylated fifth-generation polyamidoamine dendrimers in water and methanol |
| Q31144684 | Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery. |
| Q35488068 | Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy |
| Q37344163 | Multifunctional micellar nanomedicine for cancer therapy |
| Q38383487 | Multifunctional nanomedicines: potentials and prospects |
| Q36969145 | Multifunctional nanoparticulate polyelectrolyte complexes |
| Q35227397 | Multivalent conjugation of antibody to dendrimers for the enhanced capture and regulation on colon cancer cells |
| Q27692689 | Multivalent polymers for drug delivery and imaging: the challenges of conjugation |
| Q38045814 | Myconanotechnology in agriculture: a perspective |
| Q37087186 | N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers |
| Q58691550 | Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives |
| Q29616699 | Nanocarriers as an emerging platform for cancer therapy |
| Q34093260 | Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis |
| Q33681168 | Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer |
| Q37668451 | Nanomaterial standards for efficacy and toxicity assessment |
| Q33689872 | Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect |
| Q28075999 | Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective |
| Q37281194 | Nanomedicine in cerebral palsy |
| Q30481471 | Nanomedicine strategies for molecular targets with MRI and optical imaging. |
| Q35063603 | Nanomedicine strategies for treatment of secondary spinal cord injury |
| Q37189571 | Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer. |
| Q34391939 | Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations |
| Q36809026 | Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? |
| Q48827574 | Nanoparticle therapeutics: a personal perspective |
| Q43106177 | Nanoparticles as smart treatment-delivery systems in plants: assessment of different techniques of microscopy for their visualization in plant tissues. |
| Q37055363 | Nanoparticles for drug delivery in cancer treatment |
| Q34655287 | Nanoparticles in medicine: therapeutic applications and developments |
| Q38032893 | Nanoparticles-mediated drug delivery approaches for cancer targeting: a review |
| Q42009342 | Nanoparticles: Emerging carriers for drug delivery |
| Q36481101 | Nanotechnology for cancer diagnostics: promises and challenges |
| Q59049899 | Nanotechnology in Cancer Drug Delivery and Selective Targeting |
| Q36865560 | Nanotechnology safety concerns revisited |
| Q57817213 | Nanotechnology, from quantum mechanical calculations up to drug delivery |
| Q28394719 | Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review |
| Q33219919 | Nanotechnology-based drug delivery for cancer |
| Q52597834 | Nanotoxicology: a personal perspective. |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q36840545 | Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers. |
| Q92431342 | Neuroligin-2-derived peptide-covered polyamidoamine-based (PAMAM) dendrimers enhance pancreatic β-cells' proliferation and functions |
| Q34504894 | New Dendrimers: Synthesis and Characterization of Popam - Pamam Hybrid Dendrimers |
| Q36352418 | Nitric oxide-releasing dendrimers as antibacterial agents |
| Q33967988 | Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice |
| Q36714891 | Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass |
| Q50220612 | Novel advances in targeted drug delivery |
| Q47311488 | Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis. |
| Q36945847 | Nucleoside analogue delivery systems in cancer therapy |
| Q34341980 | Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. |
| Q35153697 | Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks |
| Q35602796 | Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors |
| Q37729293 | PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice |
| Q33617851 | Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation. |
| Q35997103 | Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review. |
| Q42528833 | Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. |
| Q33520512 | Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications |
| Q38809792 | Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM. |
| Q35688131 | Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate. |
| Q41885592 | Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties |
| Q33927446 | Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques |
| Q37216165 | Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery |
| Q42945507 | Polycationic Nanodrug Covered with Hyaluronic Acid for Treatment of P-Glycoprotein Overexpressing Cancer Cells |
| Q36561667 | Polymer conjugates as anticancer nanomedicines |
| Q36029175 | Polymeric conjugates for drug delivery |
| Q48184123 | Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting. |
| Q35687951 | Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic |
| Q35088842 | Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent |
| Q38149992 | Potential applications of nanoshells in biomedical sciences |
| Q38644304 | Practical theoretic guidance for the design of tumor-targeting agents. |
| Q42279261 | Precision spherical nucleic acids for delivery of anticancer drugs. |
| Q38509638 | Preclinical studies of dendrimer prodrugs |
| Q59128137 | Preparation and Characterization of Inulin Coated Gold Nanoparticles for Selective Delivery of Doxorubicin to Breast Cancer Cells |
| Q38784185 | Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. |
| Q37760212 | Progress in nanotechnology for healthcare |
| Q34145405 | Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles |
| Q51792729 | Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform. |
| Q34062177 | RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies. |
| Q37597161 | RNA interference technologies and therapeutics: from basic research to products |
| Q26778234 | Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging |
| Q27011503 | Recent advances in engineering polyvalent biological interactions |
| Q38084739 | Receptor-based targeting of therapeutics. |
| Q39162620 | Receptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assembly |
| Q34117099 | Review: update on selection of optimal radiopharmaceuticals for clinical trials |
| Q36587116 | S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles |
| Q38219592 | Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets |
| Q37184228 | Silicon micro- and nanofabrication for medicine |
| Q33385557 | Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery |
| Q57348506 | Smart dendrimer-based nanogel for enhancing 5-fluorouracil loading efficiency against MCF7 cancer cell growth |
| Q41084143 | Solid-state NMR reveals the hydrophobic-core location of poly(amidoamine) dendrimers in biomembranes |
| Q37328745 | Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles. |
| Q28396331 | Stoichiometry and Structure of Poly(amidoamine) Dendrimer-Lipid Complexes |
| Q37771241 | Strategies in the design of nanoparticles for therapeutic applications |
| Q35485272 | Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers |
| Q40108825 | Studies on polyamidoamine dendrimers as efficient gene delivery vector |
| Q30657631 | Studying biological membranes with extended range high-speed atomic force microscopy |
| Q37638513 | Superparamagnetic Nanoparticles for Atherosclerosis Imaging |
| Q38899902 | Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges. |
| Q37564495 | Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications |
| Q46641358 | Surface-enhanced Raman scattering spectroscopy as a sensitive and selective technique for the detection of folic acid in water and human serum |
| Q57097849 | Sustained analgesia achieved through esterase-activated morphine prodrugs complexed with PAMAM dendrimer |
| Q36983844 | Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alphavbeta3 integrins. |
| Q45012319 | Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel |
| Q38837904 | Synthesis and evaluation of a glutamic acid-modified hPAMAM complex as a promising versatile gene carrier |
| Q39958380 | Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting |
| Q51732673 | Synthesis and in vitro experiments of carcinoma vascular endothelial targeting polymeric nano-micelles combining small particle size and supermagnetic sensitivity. |
| Q37394856 | Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates |
| Q38753654 | Synthesis of a novel PEGDGA-coated hPAMAM complex as an efficient and biocompatible gene delivery vector: an in vitro and in vivo study |
| Q34684423 | Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting |
| Q33732629 | Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. |
| Q64121069 | Targeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed Micelles |
| Q35792897 | Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles |
| Q38693341 | Targeted Nanotherapies for the Treatment of Surgical Diseases |
| Q35184402 | Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma |
| Q33941281 | Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach |
| Q31169933 | Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement |
| Q38781307 | Targeted radionuclide therapy |
| Q39030019 | Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells. |
| Q39092356 | Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy |
| Q33640555 | Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo |
| Q42539694 | Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles |
| Q30529631 | The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow |
| Q38972723 | The application of antitumor drug-targeting models on liver cancer |
| Q35903428 | The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistry |
| Q37119874 | The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. |
| Q36294096 | The role of nanobiotechnology in drug discovery |
| Q36244267 | Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy |
| Q37171165 | Tumour and dendrimers: a review on drug delivery aspects. |
| Q26785347 | Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting |
| Q37694413 | Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals |
| Q36463444 | Utilizing the folate receptor for active targeting of cancer nanotherapeutics |
| Q39158035 | Why I believe nanoparticles are crucial as a carrier for targeted drug delivery |
| Q34076571 | Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications |
Search more.